Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Quell Therapeutics

Request full access

Engineered T-regulatory cell therapies for immune-driven diseases

London, United KingdomFounded 2019Biotech & Life Sciences

Quell Therapeutics in the London ecosystem

Live from Dealroom

The Quell Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

17 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • AlbionVC
  • UCL Technology Fund
  • Syncona

Series B and later14 investors entered at this stage

  • Monashee Investment Management
  • Medizinische Hochschule Hannover
  • Ridgeback Capital
  • King's College London
  • British Patient Capital
  • Janus Henderson Investors
  • Breakthrough Energy Ventures
  • University College London
  • Future Fund
  • Jeito Capital
  • Fidelity Investments
  • SV Health Investors
  • Tekla Capital Management
  • Point72 Ventures

Ownership

Share of equity by holder

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

35.2% Syncona Limited

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇬🇧 United Kingdom · London HQ
Book a demo for the full country breakdown

See Quell Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.